Janux Therapeutics, Inc. · NASDAQ:JANX
Ra Capital Management, L.P. reported a 19.90% stake in Janux Therapeutics, Inc. (Schedule 13D/A)
Event Mar 6, 2025 · Filed Mar 10, 2025
Ra Capital Management, L.P. reported a 19.90% stake in Janux Therapeutics, Inc., 11,971,377 shares, with active intent on Mar 6, 2025. Filed Mar 10, 2025 (Schedule 13D/A).
- Stake
- 19.90%
- Shares
- 11,971,377
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 19.90% | 11,971,377 |
| Peter Kolchinsky | 19.90% | 11,971,377 |
| Rajeev Shah | 19.90% | 11,971,377 |
| RA Capital Healthcare Fund, L.P. | 18.20% | 10,861,013 |
Source
Related
- Janux Therapeutics, Inc.
- Ra Capital Management, L.P.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026